Chinese medicinal composition treating toxoplasmosis

Abstract

The invention provides a Chinese medicinal composition treating toxoplasmosis. Being an orally taken medicine, the Chinese medicinal composition contains the following four herbal medicines: astragalus, artemisia apiacea, licorice, and betel nuts, and can be used for treating toxoplasmosis in human and animals. The Chinese medicinal composition can be decocted in water and then used directly, and also can be made into an oral liquid, a tablet and other orally taken medicines for clinical use. Drugs prepared from the Chinese medicinal composition involved in the invention have good effects and low prices.

Description

technical field [0001] The invention relates to the field of medicine, and more specifically relates to a traditional Chinese medicine composition for treating toxoplasmosis. Background technique [0002] Toxoplasma gondii is an intracellular parasite (a zoonotic disease) that exists in human cells in two forms: cysts and trophozoites (adults). Normal function, reduce the body's own innate immunity. The patient has no obvious symptoms in the early stage of the disease, and when the immunity is low to a certain extent, when other diseases attack, the toxoplasmosis is covered by other diseases, resulting in the delay of the disease. [0003] At present, conventional treatment generally adopts orally imported spiramycin. The course of treatment is 49 days, and the drug is stopped for 7 days in the middle to reduce the adverse reactions caused by side effects. Oral sulfa drugs are also useful. It can only inhibit the reproduction of trophozoites, but not kill the trophozoites....

AI Technical Summary

Problems solved by technology

[0006] The four-drug compound prescription has been clinically verified to be effective against toxoplasmosis. At present, there is no prescription in China that uses the four-drug as the main drug.